gptkbp:instance_of
|
gptkb:pharmaceuticals
|
gptkbp:affiliation
|
gptkb:Glaxo_Smith_Kline
gptkb:Smith_Kline_Beecham
|
gptkbp:alma_mater
|
gptkb:University_of_St_Andrews
gptkb:University_of_Edinburgh
|
gptkbp:awards
|
gptkb:Nobel_Prize_in_Physiology_or_Medicine
|
gptkbp:birth_date
|
1924-06-14
|
gptkbp:birth_place
|
gptkb:Bristol,_England
|
gptkbp:children
|
gptkb:3
|
gptkbp:contribution
|
improved treatment for heart conditions
improved treatment for ulcers
|
gptkbp:death_date
|
2010-03-22
|
gptkbp:death_place
|
gptkb:London,_England
|
gptkbp:field
|
gptkb:Medicine
pharmacology
|
https://www.w3.org/2000/01/rdf-schema#label
|
James W. Black
|
gptkbp:influence
|
gptkb:Health_Insurance
patient safety
therapeutic drug monitoring
clinical trials
research funding
medical education
evidence-based medicine
medical ethics
clinical pharmacology
drug regulation
pharmaceutical industry practices
modern pharmacology
cardiovascular therapy
gastrointestinal therapy
|
gptkbp:influenced
|
cardiology
drug development
gastroenterology
|
gptkbp:invention
|
gptkb:ranitidine
gptkb:atenolol
gptkb:metoprolol
gptkb:cimetidine
propranolol
|
gptkbp:known_for
|
pharmaceutical innovations
development of propranolol
clinical applications of H2-receptor antagonists
clinical applications of beta-blockers
development of cimetidine
|
gptkbp:legacy
|
impact on patient care
impact on medical research
impact on drug design
|
gptkbp:nationality
|
gptkb:British
|
gptkbp:occupation
|
gptkb:Inventor
gptkb:Scientist
|
gptkbp:research_focus
|
beta-blockers
H2-receptor antagonists
|
gptkbp:residence
|
gptkb:United_Kingdom
|
gptkbp:spouse
|
Margaret Black
|
gptkbp:bfsParent
|
gptkb:University_of_Wisconsin
|
gptkbp:bfsLayer
|
5
|